SCHEMBL21378060

SCHEMBL21378060

Cc1ccc2c(c1)c1ccccc1n2-c1cc(-c2cccc(-n3c4ccccc4c4cccnc43)c2)cc(-n2c3ccccc3c3cc(C)ccc32)c1C#N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
ELANE P08246 6/20 0.34
PDE10A Q9Y233 3/20 0.34
CYP11B2 P19099 1/20 0.34
KDM4E B2RXH2 1/20 0.32
S1PR4 O95977 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
S1PR1 P21453 1/20 0.32
F2 P00734 1/20 0.32
PLAU P00749 1/20 0.32
CTRB1 P17538 1/20 0.32
NTRK1 P04629 1/20 0.32
PIM1 P11309 1/20 0.32
RECQL P46063 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
KDM4D Q6B0I6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21397085 0.90 PDE10A (0.35) ALDH1A1TSHRCYP2C19ELANEPDE10A
SCHEMBL21377976 0.90 ALDH1A1 (0.35) ALDH1A1TSHRCYP2C19CYP11B2KDM4E
SCHEMBL21377997 0.89 GABRA1 (0.34) ALDH1A1TSHRCYP2C19CYP11B2KDM4E
SCHEMBL21396579 0.88 ALDH1A1 (0.35) ALDH1A1TSHRCYP2C19CYP11B2KDM4E
SCHEMBL21396868 0.86 ALDH1A1 (0.34) ALDH1A1TSHRCYP2C19ELANEPDE10A
SCHEMBL21396583 0.86 ALDH1A1 (0.34) ALDH1A1TSHRCYP2C19ELANEPDE10A
SCHEMBL21396894 0.85 CYP11B2 (0.39) ALDH1A1ELANECYP11B2KDM4ES1PR4
SCHEMBL21378046 0.85 CYP11B2 (0.39) ALDH1A1ELANECYP11B2KDM4ES1PR4
SCHEMBL21396835 0.84 ALDH1A1 (0.37) ALDH1A1TSHRCYP2C19CYP11B2KDM4E
SCHEMBL25920236 0.83 ALDH1A1 (0.40) ALDH1A1TSHRCYP2C19PDE10AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11608333-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-03-21 US disclosed
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885TSHR 4805/4885CYP2C19 795/4885
US-11608333-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885TSHR 4805/4885CYP2C19 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.